Vaccine formulation for a single 2 mL dose.

“R” is denoted for rank of gene or protein. The vaccine for group A (placebo/control group) did not contain antigens. The vaccine for groups B, C and D contained antigens (R2, R5, R8, R18, R27, R37), (R13, R15, R21, R24, R34, R36) and (R1, R4, R22, R23, R35) respectively. Emulsigen and CpG oligodeoxynucleotides were used together to achieve a balanced Th1/Th2 immune response.

以“R”指代基因或蛋白质的排序编号。A组疫苗（安慰剂/对照组）不含抗原。B、C、D组疫苗分别包含抗原组合(R2、R5、R8、R18、R27、R37)、(R13、R15、R21、R24、R34、R36)与(R1、R4、R22、R23、R35)。本研究联合使用Emulsigen与CpG寡脱氧核苷酸，以诱导出均衡的Th1/Th2型免疫应答。